CINC CinCor Pharma Inc

CinCor Pharma, Inc. (NASDAQ: CINC) today announced that company management will participate at the Jefferies London Healthcare Conference taking place on November 15-17, 2022 in London, United Kingdom. The presentation information is below:

Jefferies London Healthcare Conference
Presentation:	Wednesday, November 16, 2022 at 5 PM GMT
Location:	Track 2 – Room, Adelphi 2, Ground Level at the Waldorf Hilton

The CinCor management team will participate in one-on-one investor meetings during the event. Investors interested in meeting with CinCor at the conference should contact their Jefferies representative.

About CinCorCinCor, founded in 2018, is a clinical-stage biopharmaceutical company with a mission to bring innovation to the pharmaceutical treatment of cardio-renal diseases. Its lead asset, baxdrostat, a highly selective, oral small molecule inhibitor of aldosterone synthase, is in clinical development for the treatment of hypertension and primary aldosteronism.

Contacts:		Investors:
Mike Kalb		Bob Yedid
CinCor Pharma, Inc.		LifeSci Advisors
EVP and CFO		ir@CinCor.com